本立科技(301065.SZ)：公司取得《药品生产许可证》

Core Viewpoint - The company has obtained its first "Drug Production License" from the Zhejiang Provincial Drug Administration, which is expected to optimize its product structure and positively impact long-term development [1] Group 1: License Acquisition - The acquisition of the "Drug Production License" marks the company's first achievement in this area [1] - The license will facilitate the optimization of the company's product structure [1] Group 2: Future Steps - The company must complete registration, on-site verification, and obtain raw material drug filing approval before commercial production and sales can commence [1] - The immediate impact of the license on the company's operating performance is expected to be minimal [1]